Overview

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

Status:
Completed
Trial end date:
1996-02-01
Target enrollment:
Participant gender:
Summary
To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Alprazolam